SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-10-051795
Filing Date
2010-10-22
Accepted
2010-10-22 17:11:40
Documents
2
Period of Report
2010-10-21

Document Format Files

Seq Description Document Type Size
1 rrd288193.html 3  
1 rrd288193.xml 3 2837
2 LIMITED POWER OF ATTORNEY rrd258385_292158.htm EX-24.1 5961
  Complete submission text file 0001181431-10-051795.txt   10665
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ACHILLION PHARMACEUTICALS 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Scheer David (Reporting) CIK: 0001378585 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34921 | Film No.: 101137873